Twelve-month self-reported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36)

2006 ◽  
Vol 97 (2) ◽  
pp. 274-278 ◽  
Author(s):  
VINCENZO FICARRA ◽  
GIACOMO NOVARA ◽  
ANTONIO GALFANO ◽  
CARLO STRINGARI ◽  
ROBERTO BALDASSARRE ◽  
...  
2018 ◽  
Vol 4 ◽  
pp. 233372141878281 ◽  
Author(s):  
Esmeralda Valdivieso-Mora ◽  
Mirjana Ivanisevic ◽  
Leslie A. Shaw ◽  
Mauricio Garnier-Villarreal ◽  
Zachary D. Green ◽  
...  

Surgery Today ◽  
2013 ◽  
Vol 44 (2) ◽  
pp. 264-270 ◽  
Author(s):  
Timuçin Alar ◽  
Kenan Can Ceylan ◽  
Seyda Ors Kaya ◽  
Serpil Sevinç ◽  
Deniz Sigirli ◽  
...  

Urology ◽  
2013 ◽  
Vol 81 (4) ◽  
pp. 781-786 ◽  
Author(s):  
Viktor Berge ◽  
Rolf E. Berg ◽  
Jon R. Hoff ◽  
Nicolai Wessel ◽  
Lien M. Diep ◽  
...  

2021 ◽  
Vol 10 (1) ◽  
pp. 289-295
Author(s):  
Sihombing JP ◽  
Nasution AT ◽  
Sitanggang H

Objective: To elicit quality of life of chronic kidney disease (CKD) patients with routine hemodialysis receiving erythropoietin from clinical and humanistic outcome, to analysis characteristic factors to Hb, fatique and the quality of life (QOL) of CKD patients with routine hemodialysis, and to explore the change in QOL over one month for patients managed in the hospitals. Methods: A prospective study was conducted among adult CKD patients in Haji Adam Malik Hospital Medan. QOL was measured using kidney disease quality of life – short form (KDQOL–SFTM) questionnaire and FACIT fatigue scale questionnaire. CKD patients. Patients were asked to complete the KDQOL–SFTM questionnaire and FACIT fatigue scale questionnaire two times in one month range. Results: Average rate of haemoglobin was increased after one month anemia treatment using erythropoietin 8.68: 8.82. Average rate of FACIT was increased after one month anemia treatment using erythropoietin 43.98: 44.81. Average rate of KDQOL was increased after one month anemia treatment using erythropoietin 76.83: 77.94. Conclusion: Erythropoietin can improve QOL of CKD patients with routine hemodialysis.


2008 ◽  
Vol 57 (4) ◽  
pp. 339-346 ◽  
Author(s):  
Masato Muraki ◽  
Hideo Ichihashi ◽  
Ryuta Haraguchi ◽  
Takashi Iwanaga ◽  
Hirokazu Kubo ◽  
...  

2010 ◽  
Vol 27 (12) ◽  
pp. 2173-2181 ◽  
Author(s):  
Mathew R. Guilfoyle ◽  
Helen M. Seeley ◽  
Elizabeth Corteen ◽  
Christine Harkin ◽  
Hugh Richards ◽  
...  

2015 ◽  
Vol 31 (4) ◽  
pp. 257-263 ◽  
Author(s):  
CB van de Pas ◽  
AAM Biemans ◽  
RSM Boonen ◽  
PB Viehoff ◽  
HAM Neumann

Background The Lymphoedema Quality-of-Life Questionnaire is a validated disease-specific instrument to measure the impact of lymphoedema on patients’ lives. In this study, we tested its psychometric properties and validated the use of the questionnaire in its Dutch translation. Methods We obtained the answers to a standardised questionnaire, including Lymphoedema Quality-of-Life Questionnaire and Short-Form (36) Health Survey, twice at an interval of 2 weeks in 60 patients with lower limb lymphoedema. Feasibility was tested on the basis of missing responses and response distribution. Structure was studied using factor analysis. The reliability of the Lymphoedema Quality-of-Life Questionnaire was assessed using Crohnbach’s α and test-retest reliability. Construct validity was tested by correlating Lymphoedema Quality-of-Life Questionnaire scores with the Short-Form (36) Health Survey scores. Results The response rate was 88.2%. One of the 22 items missed >10% of responses; another showed a borderline ceiling effect. Internal consistency was good and test-retest reliability was excellent. The Lymphoedema Quality-of-Life Questionnaire correlated well with the physical component of the Short-Form (36) Health Survey and moderately with the mental component, suggesting that its construct validity was good. Conclusion The Dutch Lymphoedema Quality-of-Life Questionnaire can be used for health-related quality-of-life research in lower limb lymphoedema patients.


2010 ◽  
Vol 124 (8) ◽  
pp. 835-841 ◽  
Author(s):  
H S Chew ◽  
S Yeak

AbstractBackground:Hearing loss commonly affects quality of life in the elderly, yet is often neglected.Objectives:To investigate the impact of untreated age-related hearing loss on the quality of life of elderly individuals, and to assess the usefulness of quality of life questionnaires as screening tools for significant hearing loss.Methods:We recruited 80 patients aged 50 years or more with untreated hearing impairment. The Short Form 36 Health Survey and the Hearing Handicap Inventory for the Elderly Screening Version questionnaire were administered.Results:There was no significant association between severity of hearing impairment and Short Form 36 Health Survey scores. However, dose-graded correlation was observed between severity of hearing loss and Hearing Handicap Inventory for the Elderly Screening Version questionnaire scores (p < 0.001). A score for the latter questionnaire of more than 8 was 72.8 per cent sensitive and 71.4 per cent specific in detecting clinically significant hearing loss of at least 40 dB (receiver operating characteristic = 0.83).Conclusion:The Short Form 36 Health Survey, a generic measure, lacked specificity and sensitivity in detecting clinically significant hearing loss. However, significant hearing impairment was reflected in the Hearing Handicap Inventory for the Elderly Screening Version questionnaire scores, suggesting that this is a good, disease-specific screening tool. A combination of functional (i.e. the Hearing Handicap Inventory for the Elderly Screening Version questionnaire) and physiological (i.e. audiometric) assessment is recommended to investigate hearing loss in elderly individuals.


2015 ◽  
Vol 26 (2) ◽  
pp. 240-247 ◽  
Author(s):  
Makio Furukawa ◽  
Chikako Kiyohara ◽  
Takahiko Horiuchi ◽  
Hiroshi Tsukamoto ◽  
Hiroki Mitoma ◽  
...  

Neurosurgery ◽  
2011 ◽  
Vol 69 (3) ◽  
pp. 689-695 ◽  
Author(s):  
Thomas Dukatz ◽  
Johannes Sarnthein ◽  
Helmut Sitter ◽  
Oliver Bozinov ◽  
Ludwig Benes ◽  
...  

Abstract BACKGROUND: Symptomatic patients with a brainstem cavernoma are treated surgically with increasing frequency. Generally, the patient's benefit from this difficult surgical intervention is quantified by the assessment of neurological symptoms. OBJECTIVE: To document the beneficial effect of surgery in a larger patient population by assessing the postoperative quality of life (QoL). METHODS: In a series of 71 surgically treated patients, a detailed neurological status was assessed by Patzold Rating and Karnofsky Performance Status Scale. Patients rated their QoL with the Short Form 36 Health Survey. To document the effect of surgery on QoL, we devised a supplementary questionnaire. The last 24 patients completed Short Form 36 Health Survey pre- and postoperatively. RESULTS: Karnofsky Performance Status Scale improved in 44 of 71 surgical patients (62%), remained unchanged in 19 (27%), and deteriorated in 8 (11%) individuals. Patzold Rating showed a more detailed picture of the neurological symptoms. It correlated significantly with Karnofsky Performance Status Scale, which underscores its usefulness for patients with brainstem lesions. In the Short Form 36 Health Survey score, the Mental Component Summary improved with surgery (paired test, P = .015). In addition, 58 individuals (82%) declared a clear subjective benefit of surgery. CONCLUSION: The results of this large series support the notion that microsurgical removal of a brainstem cavernoma represents an effective therapy in experienced hands and is generally associated with good clinical outcome, both neurologically and in terms of QoL.


Sign in / Sign up

Export Citation Format

Share Document